In non-endemic countries, acute (invasive) schistosomiasis (AS) is typically seen in non-
immune travellers, whereas chronic schistosomiasis is more frequently diagnosed in …

This review considers the current status of urinary schistosomiasis, caused by infection with
Schistosoma haematobium, and argues that greater research effort and focus are needed to …

Differences in the state of health between rural and urban populations living in Africa have
been described, yet only few studies analysed inequities within poor rural communities. We …

Remarkable achievements have been made in the control of schistosomiasis in China, with
chemotherapy playing a seminal role. From the early 1950s through the early 1980s …

Schistosomiasis is a neglected parasitic tropical disease that claims around 200,000 human
lives every year. Praziquantel (PZQ), the only drug recommended by the World Health …

Artemisinin-based combination therapies are increasingly deployed against malaria, and
hence there is a need to assess the potential auxiliary effects against schistosomiasis in …

Background Recent research has suggested that artemisinin and its derivatives may have
therapeutic effects on parasites, viruses, tumors, inflammation and skin diseases. This study …

With just one drug used for individual patient management and community-based morbidity
control, the treatment, control, and eventual elimination of schistosomiasis is vulnerable …

The stumbling block for the continued, single-drug use of praziquantel (PZQ) against
schistosomiasis is less justified by the risk of drug resistance than by the fact that this drug is …

Schistosomiasis is a debilitating disease affecting approximately 600 million people in 74
developing countries, with 800 million, mostly children at risk. To circumvent the threat of …